nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A history of pharmacoepidemiology
|
Bégaud, Bernard |
|
2019 |
74 |
2 |
p. 175-179 |
artikel |
2 |
Case–non-case studies: Principle, methods, bias and interpretation
|
Faillie, Jean-Luc |
|
2019 |
74 |
2 |
p. 225-232 |
artikel |
3 |
Editorial board
|
|
|
2019 |
74 |
2 |
p. i |
artikel |
4 |
French administrative health care database (SNDS): The value of its enrichment
|
Scailteux, Lucie-Marie |
|
2019 |
74 |
2 |
p. 215-223 |
artikel |
5 |
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes
|
Salvo, Francesco |
|
2019 |
74 |
2 |
p. 255-260 |
artikel |
6 |
Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution
|
Dupui, Mathilde |
|
2019 |
74 |
2 |
p. 307-314 |
artikel |
7 |
Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs
|
Lapeyre-Mestre, Maryse |
|
2019 |
74 |
2 |
p. 209-214 |
artikel |
8 |
Interest of pharmacoepidemiology for the study of antibiotic drugs
|
Sommet, Agnès |
|
2019 |
74 |
2 |
p. 249-253 |
artikel |
9 |
Interest of pharmacoepidemiology for the study of anticoagulants
|
Bagheri, Haleh |
|
2019 |
74 |
2 |
p. 245-248 |
artikel |
10 |
Interest of pharmacoepidemiology for the study of inhaled drugs
|
Molimard, Mathieu |
|
2019 |
74 |
2 |
p. 233-237 |
artikel |
11 |
Interest of pharmacoepidemiology for the study of psychotropic drugs
|
Tournier, M. |
|
2019 |
74 |
2 |
p. 239-244 |
artikel |
12 |
Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity
|
Abou Taam, Malak |
|
2019 |
74 |
2 |
p. 301-306 |
artikel |
13 |
Methods in pharmacoepidemiology
|
Sommet, Agnès |
|
2019 |
74 |
2 |
p. 187-197 |
artikel |
14 |
Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics
|
Kaguelidou, Florentia |
|
2019 |
74 |
2 |
p. 315-324 |
artikel |
15 |
Pharmacoepidemiology in older people: Purposes and future directions
|
Laroche, Marie-Laure |
|
2019 |
74 |
2 |
p. 325-332 |
artikel |
16 |
Pharmacoepidemiology in pregnancy
|
Benevent, Justine |
|
2019 |
74 |
2 |
p. 289-300 |
artikel |
17 |
Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
|
Moore, Nicholas |
|
2019 |
74 |
2 |
p. 271-277 |
artikel |
18 |
Pharmacoepidemiology of statins
|
Bezin, Julien |
|
2019 |
74 |
2 |
p. 261-269 |
artikel |
19 |
Pharmacoepidemiology, the new paradigm of drug evaluation
|
Bégaud, Bernard |
|
2019 |
74 |
2 |
p. 167-168 |
artikel |
20 |
The limitations of observation studies for decision making regarding drugs efficacy and safety
|
Gueyffier, François |
|
2019 |
74 |
2 |
p. 181-185 |
artikel |
21 |
The systematic case-referent method
|
Grimaldi-Bensouda, Lamiae |
|
2019 |
74 |
2 |
p. 199-207 |
artikel |
22 |
The value of a health insurance database to conduct pharmacoepidemiological studies in oncology
|
Conte, Cécile |
|
2019 |
74 |
2 |
p. 279-288 |
artikel |
23 |
What is pharmacoepidemiology? Definition, methods, interest and clinical applications
|
Montastruc, Jean-Louis |
|
2019 |
74 |
2 |
p. 169-174 |
artikel |